6-Month Buy/Sell Trend
Buys
Sells
▶
2026-04-20
▲ 3 buys
· $167.4M
19 other
⚡ 8 insiders
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Jiangsu Hengrui Pharmaceuticals Co., Ltd. | — | C | 9,477,719 | — | — | Apr 22 | |
| Jiangsu Hengrui Pharmaceuticals Co., Ltd. | — | C | 2,034,133 | — | — | Apr 22 | |
| Jiangsu Hengrui Pharmaceuticals Co., Ltd. | — | C | 4,968,789 | $0 | $0 | Apr 22 | |
| Jiangsu Hengrui Pharmaceuticals Co., Ltd. | — | C | 708,814 | $0 | $0 | Apr 22 | |
| RTW INVESTMENTS, LP | — | C | 10,276,820 | — | — | Apr 22 | |
| RTW INVESTMENTS, LP | — | ▲ Buy | 500,000 | $16 | $8.0M | Apr 22 | |
| RTW INVESTMENTS, LP | — | C | 8,250,000 | — | — | Apr 22 | |
| RTW INVESTMENTS, LP | — | C | 2,026,820 | — | — | Apr 22 | |
| BAIN CAPITAL INVESTORS LLC | — | C | 17,857,143 | — | — | Apr 20 | |
| BAIN CAPITAL INVESTORS LLC | — | C | 17,857,143 | $0 | $0 | Apr 20 | |
| Bain Capital Life Sciences Investors, LLC | — | C | 16,875,000 | — | — | Apr 20 | |
| Bain Capital Life Sciences Investors, LLC | — | C | 4,145,768 | — | — | Apr 20 | |
| Bain Capital Life Sciences Investors, LLC / Koppel Adam | — | ▲ Buy | 1,562,500 | $16 | $25.0M | Apr 20 | |
| Bain Capital Life Sciences Investors, LLC | — | C | 16,875,000 | $0 | $0 | Apr 20 | |
| Bain Capital Life Sciences Investors, LLC | — | C | 4,145,768 | $0 | $0 | Apr 20 | |
| Kaplan Andrew T. | — | C | 17,857,143 | — | — | Apr 20 | |
| Kaplan Andrew T. / BAIN CAPITAL INVESTORS LLC | — | ▲ Buy | 8,398,438 | $16 | $134.4M | Apr 20 | |
| Kaplan Andrew T. | — | C | 17,857,143 | $0 | $0 | Apr 20 | |
| Koppel Adam | — | C | 16,875,000 | — | — | Apr 20 | |
| Koppel Adam | — | C | 4,145,768 | — | — | Apr 20 | |
| Koppel Adam | — | C | 16,875,000 | $0 | $0 | Apr 20 | |
| Koppel Adam | — | C | 4,145,768 | $0 | $0 | Apr 20 |
▶
2026-04-16
20 other
⚡ 13 insiders
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Akamine Scott | Chief Legal Officer | A | 60,000 | $0 | $0 | Apr 20 | |
| Akamine Scott | Chief Legal Officer | A | 60,000 | $0 | $0 | Apr 20 | |
| Burgess Paul D. | See Remarks | A | 100,000 | $0 | $0 | Apr 20 | |
| Burgess Paul D. | See Remarks | A | 100,000 | $0 | $0 | Apr 20 | |
| Cloghessy Paula | Chief People Officer | A | 60,000 | $0 | $0 | Apr 20 | |
| Cloghessy Paula | Chief People Officer | A | 60,000 | $0 | $0 | Apr 20 | |
| Clyburn Frank | — | A | 38,300 | $0 | $0 | Apr 20 | |
| Coleman Jamie Beth | Chief Commercial Officer | A | 75,000 | $0 | $0 | Apr 20 | |
| Coleman Jamie Beth | Chief Commercial Officer | A | 75,000 | $0 | $0 | Apr 20 | |
| Hite Christopher | — | A | 38,300 | $0 | $0 | Apr 20 | |
| Pagan Douglas W. | Chief Financial Officer | A | 100,000 | $0 | $0 | Apr 20 | |
| Pagan Douglas W. | Chief Financial Officer | A | 100,000 | $0 | $0 | Apr 20 | |
| Wasserman Scott M. | Chief Medical Officer | A | 100,000 | $0 | $0 | Apr 20 | |
| Wasserman Scott M. | Chief Medical Officer | A | 100,000 | $0 | $0 | Apr 20 | |
| MACKAY MARTIN | — | A | 38,300 | $0 | $0 | Apr 20 | |
| MILLIGAN JOHN F | — | A | 38,300 | $0 | $0 | Apr 20 | |
| Renaud Ronald C JR | CEO & President | A | 300,000 | $0 | $0 | Apr 20 | |
| Renaud Ronald C JR | CEO & President | A | 300,000 | $0 | $0 | Apr 20 | |
| Kaplan Andrew T. | — | A | 38,300 | $0 | $0 | Apr 20 | |
| Koppel Adam | — | A | 38,300 | $0 | $0 | Apr 20 |